A company focused on oncology and international leadership in healthcare.

Boston Oncology

Bold and nimble, Boston Oncology is an innovative biogenerics company redefining excellence in the licensing and local development, manufacturing and distribution of US- quality medicines – across therapeutic areas.

From our nerve center in Riyadh, we leverage the expertise, daring creativity, and unwavering determination of our international leadership team to provide customers with end-to-end, efficient, single-point-of-contact access to our diverse portfolio of world-class biogenerics.

We do this because lives depend on it.

CEO, Abdullah Baaj, MD, PharmD addressing the 2023 US Pharma Partnering Summit assembly hall—presenting the achievements and value of our innovative localization model for ROW markets. Thank you to the organizers for including Boston Oncology in this impactful event!

#PharmaPartnering #Lifescience #BostonOncology #BostonOncologyArabia #Pharmaceutical #ROWmarkets #HealthEquity #Licensing #Localization #Generics #GenericDrugs #Biosimilars #B2Bpartnering

We are excited to join forces with TVM Capital Healthcare in our mission to serve 1 billion people by 2030. This $35 million investment will expand the localization of our manufacturing, significantly enhancing the accessibility and quality of healthcare in the region. Looking forward to the journey ahead!

World Kidney Cancer Day

This year’s theme, “Listening,” serves as a two-fold reminder of the importance of paying attention to our own bodies and the power of listening carefully to patients’ experiences, needs and concerns.

Kidney cancer often has no symptoms in its early stages. Regular screenings, especially for those with risk factors such as smoking, obesity or family history, are essential.

By spreading awareness and encouraging proactive healthcare, we support informed and empowered patients—improving survival rates and quality of life for those affected by kidney cancer.

#WorldKidneyCancerDay #Listening #PatientEmpowerment #KidneyCancerAwareness #HumanizingHealthcare #BostonOncology #BostonOncologyArabia

World Ovarian Cancer Day

Often called the "silent killer," ovarian cancer is typically diagnosed in later stages. Symptoms are frequently dismissed as common digestive or menstrual issues--bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, and urinary urgency or frequency. 

Understanding the symptoms, regular medical check-ups, and access to treatment can lead to earlier diagnosis and better outcomes.

Boston Oncology is commitment to advocating for women's health and enhancing health equity by bringing affordable best-in-class oncology products to patients around the world.

#WorldOvarianCancerDay #OvarianCancerAwareness #OvarianCancer #KnowTheSigns #BostonOncology #BostonOncologyArabia

Innovating to Improve Access

The Boston Oncology team are thrilled to see our friends at Immuneel Therapeutics Pvt. Ltd. recognized among the 2023 Endpoints 11—celebrating the boldest startups with the most promising science.  

Richly deserved and arguably overdue, the accolade is especially meaningful bestowed upon a company leveraging truly disruptive #innovation to bring life-saving therapeutics to the developing world—at a small fraction of the accepted cost.

Making CAR-T accessible in India, and ultimately far beyond, is another brilliant example of the unwavering commitment of Co-Founder Kiran Mazumdar Shaw to providing affordable access to cutting-edge therapies around the globe.

Innovation is at the core the Immuneel model—from their efficient operations to their embedded facilities. Co-Founder Dr. Siddhartha Mukherjee said it best:  

“Access and innovation are inextricably linked. They are not opposed to one another. Innovation doesn’t necessarily mean making a new biological reagent. It might mean solving an engineering problem. It might mean running a new kind of trial. It might mean solving supply-chain issues.”

Wonderful recognition for an extraordinary team! And, they are just getting started. 

#Immuneel #Endpoints #EndpointsNews #Endpoints11 #SiddharthaMukherjee #DrSiddharthaMukherjee #KiranMazumdarShaw #BostonOncology #PatientCare #MedicalAccess #CellAndGeneTherapy #India #CartCellTherapy #CancerResearch

COM:BOSTONONCOLOGY

Boston Oncology

Financials Not Available